{"text": ["AbbVie", "Presents", "Late-Breaking", "Data", "on", "Risankizumab", "(SKYRIZI\u00ae)", "in", "Psoriatic", "Arthritis", "at", "the", "30th", "European", "Academy", "of", "Dermatology", "and", "Venereology", "(EADV)", "Congress"], "created_at": "2021-09-30 13:45:00"}
{"text": ["AbbVie", "Presents", "New", "Analyses", "Evaluating", "RINVOQ\u00ae", "(upadacitinib)", "in", "Atopic", "Dermatitis", "Across", "Patient", "Characteristics", "and", "Body", "Regions", "at", "EADV", "Virtual", "Congress"], "created_at": "2021-09-30 12:30:00"}
